The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs

Unconjugated anti-cancer IgG1 monoclonal antibodies (mAbs) activate antibody-dependent cellular cytotoxicity (ADCC) by natural killer (NK) cells and antibody-dependent cellular phagocytosis (ADCP) by macrophages, and these activities are thought to be important mechanisms of action for many of these...

Full description

Bibliographic Details
Main Authors: Josée Golay, Ronald P. Taylor
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/9/4/58